Delivery Order SPE2DR25D3103-SPE2DR26F9K33
- Not listed
- The Defense Logistics Agency awarded a $3,855.14 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on November 26, 2025, with an ultimate completion date of November 28, 2025. This non-set-aside delivery order utilizes firm fixed price terms and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Risperdal 0.5 mg tablets (60-count) under a firm fixed price contract valued at $2,391.54. This is a non-set-aside competitive award with an ultimate completion date of December 8, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Risperdal 4 mg tablets (60-count units) with a firm fixed price ceiling value of $2,526.04. The order was competitively awarded without set-aside designation and is scheduled for completion by November 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg, a pharmaceutical product used in neurological and psychiatric treatment. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires delivery by December 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,897.50 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count units) under a firm fixed price contract. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...
- The Defense Logistics Agency (DLA) awarded a $1,110.06 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperidone 0.25 mg, with an ultimate completion date of October 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,188.80 to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg, a pharmaceutical product used in the treatment of psychiatric conditions. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,434.33 contract is for the delivery of 60 tablets of the drug Risperdal 1 mg. The order has a completion date of January 22, 2024. This delivery order is part of AmerisourceBergen Drug Corp's existing contractual relationship with DLA Troop Support Medical to provide...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.86 to AmerisourceBergen Drug Corp for 500 tablets of Risperidone 0.25 mg. This contract, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, is a firm fixed price delivery order with no set-aside designation. The award reflects a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K33Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,675.13 firm fixed-price delivery order for 60 tablets of Risperdal 0.5 mg on December 1, 2025, with completion due by December 2, 2025. This is a non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major for-profit pharmaceutical distributor and healthcare solutions provider, supplies a broad range of medications and medical commodities to federal agencies, particularly supporting Defense Health Agency and military healthcare systems. The company's federal procurement portfolio demonstrates extensive experience delivering both brand-name and generic pharmaceuticals across multiple therapeutic domains, including neurological treatments such as Risperdal. This delivery order exemplifies the routine pharmaceutical supply needs fulfilled through AmerisourceBergen's prime vendor relationship with DLA, enabling efficient medical supply chain operations for defense and military healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/30/25 |